- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Harris & Harris Group invests $2,800,000 in Evolved Nanomaterial Sciences, Inc.
Posted on March 09, 2006
Harris & Harris Group, Inc., announced today that it led a
$3,300,000 Series A round of financing of privately held Evolved
Nanomaterial Sciences, Inc. (ENS) of Cambridge, MA. Harris &
Harris Group invested $2,800,000 in this round of financing.
ENS has developed a number of nanotechnology-enhanced approaches for the resolution of chiral molecules. ENS is using its proprietary ESPTM technology to manufacture high-capacity, high-generality HPLC columns that simplify chiral method development and chiral chromatography and purification. The A round funding will be used to fill out its manufacturing and product development capabilities and to support the launch of its first line of commercially available products.
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 27 initial private equity investments have been in tiny technology-enabled companies. The Company has 20,756,345 common shares outstanding.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.TinyTechVC.com.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016
Research reveals carbon films can give microchips energy storage capability: International team from Drexel University and Paul Sabatier University reveals versatility of carbon films February 11th, 2016
Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016
SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016
Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016